Navigation Links
Don't Rely on Jaundiced Eye for Assessing Newborns

Study Challenges Common Medical Practice

PHILADELPHIA, March 23 /PRNewswire-USNewswire/ -- For hundreds of years, doctors, nurses and midwives have visually examined newborn babies for the yellowish skin tones that signify jaundice, judging that more extensive jaundice carried a greater risk of illness.

The yellowness comes from a blood byproduct, bilirubin, and a child that develops high levels of bilirubin has a potentially serious condition called hyperbilirubinemia.

Now pediatric researchers say that this longstanding practice of visual inspection is an unreliable method of predicting the baby's risk of hyperbilirubinemia. Only infants with a total absence of visible jaundice can confidently be expected to have a very low risk of hyperbilirubinemia.

"Our study tells clinicians that our ability to estimate a baby's bilirubin level, or predict the baby's risk of developing clinically significant hyperbilirubinemia, by visually observing the extent of visual jaundice, is inadequate, and not very helpful," said study leader Ron Keren, M.D., M.P.H., a pediatrician in the Center for Pediatric Clinical Effectiveness at The Children's Hospital of Philadelphia. Keren also is a faculty member of the University of Pennsylvania School of Medicine.

The study appeared March 22 in the online version of Archives of Disease in Childhood-Fetal and Neonatal Edition.

Neonatal jaundice is very common, occurring in as many as 60 percent of newborns annually, according to the American Academy of Pediatrics. It appears as a yellow skin color, a sign of excess bilirubin, a byproduct of the normal breakdown of red blood cells. In the vast majority of cases, jaundice disappears in one to two weeks as the baby's liver reduces bilirubin to normal levels, permitting the excess to be excreted.

But extremely high levels of bilirubin can cause kernicterus, a potentially life-threatening condition that can result in long-term brain damage, hearing loss and other neurological problems. Although extremely rare, kernicterus has been increasing in the U.S. over the past two decades, leading some professional organizations to advocate universal bilirubin screening before newborns leave the hospital. The standard treatment for significant hyperbilirubinemia is phototherapy--exposing the baby to ultraviolet lights that chemically change bilirubin under the skin to a harmless form.

The current study was the first systematic analysis of jaundice assessment as a predictor of significant hyperbilirubinemia risk. It was also the largest such study, involving 522 term and late-preterm newborns.

Clinicians have long known that neonatal jaundice progresses from head to foot, as shown by yellowing of the baby's skin. In this study, conducted in the Well Baby Nursery of the Hospital of the University of Pennsylvania, nurses used a five-point scale to grade the farthest extent of jaundice along the newborn's body. The nurses who did the ratings did not know the actual bilirubin levels, which were measured by other caregivers using a noninvasive device.

On analyzing the results, the researchers found that, while there was some correlation between the extent of jaundice as rated by the nurses and the measured bilirubin levels, the extent of jaundice could not be used to estimate the bilirubin level or to accurately predict an infant's risk of developing significant hyperbilirubinemia (defined in this study as a bilirubin level for which phototherapy is recommended). Furthermore, contrary to a common belief that it is harder to visually assess jaundice in dark-skinned infants, there was no significant difference in the results between black and white newborns.

The correlation between visually assessed jaundice and bilirubin level was especially weak in late-preterm infants, those at 35 to 38 weeks gestational age. This is important, said Keren, because late-preterm infants are at greater risk of developing significant hyperbilirubinemia.

The one exception to the poor predictive value of visual assessment came in the 91 infants (17 percent of all those studied) rated by the nurses as having a complete absence of jaundice. For those infants, the actual risk of developing significant hyperbilirubinemia was extremely low, less than 1 percent. Even for those infants, said Keren, absence of visual jaundice may require a caveat. "Less experienced observers may be less capable of accurately assessing a complete absence of jaundice. All in all, the benefits of objective results from universal bilirubin screening may outweigh the benefit in reducing testing and costs from pursuing a selective screening approach."

Funding for the study came from the National Institute of Child Health and Human Development of the National Institutes of Health. Respironics of Murrysville, Pa, provided medical devices and equipment for the study. Keren's co-authors were Katie Tremont, B.S., and Xianqun Luan, M.S., both of Children's Hospital; and Avital Cnaan, Ph.D., of both Children's Hospital and the University of Pennsylvania.

About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking second in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 430-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit

    Contact: John Ascenzi
    Phone: (267) 426-6055

SOURCE The Children's Hospital of Philadelphia
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Growing Link Between Diabetes and Periodontal Disease Focus of National Gathering for Health Care Leaders
2. Treating your periodontal pockets may benefit your pocket book
3. Ortho Organizers(R) Announces the Launch of the Ancor Pro(TM) Orthodontic Anchorage System Hands-on Course
4. Survey confirms Americans prefer root canal treatment by endodontists
5. Most With High Blood Pressure Dont Follow Recommended Diet
6. Watch Your Mouth: Michigan Association of Endodontists Offers Four Part Series on Keeping Your Teeth Healthy
7. NYU dental researchers find evidence of periodontal disease leading to gestational diabetes
8. HPV, periodontitis work in tandem to increase risk of tongue cancer
9. Ortho Organizers(R) Introduces New Premium Product Line - O2 Select(TM) Orthodontic Instruments
10. Saving teeth by using periodontal ligament regeneration
11. Researchers uncover higher prevalence of periodontal disease in rheumatoid arthritis patients
Post Your Comments:
(Date:12/1/2015)... ... , ... With FCPX Overlay: Grit , users can apply a grit ... are truly endless, all with a click of a mouse. Each user has full ... depth of field and more, all within Final Cut Pro X. , With FCPX ...
(Date:12/1/2015)... ... December 01, 2015 , ... SonaCare ... 2015 HSJ Acute Sector Innovation Award on November 18th. This prestigious award recognizes ... and propose exciting enhancements to the medical landscape. , The UCLH team won ...
(Date:11/30/2015)... ... 30, 2015 , ... Olympic Gold Medalists and Celebrity Moms ... across various categories through traditional and social media marketing campaigns and other branding ... Gold Medal Moms who can connect with today’s most important consumer: mothers. In ...
(Date:11/30/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... honors Christina Colon as a 2015-2016 inductee into its VIP Woman ... in pharmacy. NAPW is the nation’s leading networking organization exclusively for professional women, ...
(Date:11/30/2015)... Los Angeles, California (PRWEB) , ... November 30, ... ... in all the programs of the19th Bi-National Convention of the Federation of Philippine ... Resort and Casino in Las Vegas, Nevada. , 1Heart Caregiver Services, as ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015  Roche ... wholly-owned UK subsidiary Proximagen Ltd., today announced a worldwide ... small molecule inhibitor of Vascular Adhesion Protein 1 (VAP-1), ... treatment of inflammatory disease. The VAP-1 inhibitor is currently ... --> Under the terms of the ...
(Date:11/30/2015)... LOUIS , Dec. 1, 2015 Express Scripts ... Imprimis Pharmaceuticals (NASDAQ: IMMY ) to drive access to ... for the treatment of toxoplasmosis that has been recently priced ... others with weakened immune systems. --> ... of pyrimethamine and leucovorin (a form of folic acid) for $1 ...
(Date:11/30/2015)... Die MEDTEC Japan 2016, ... Entwicklung und Herstellung medizinischer Geräte, findet ... in Tokyo ... Foto: ... --> ...
Breaking Medicine Technology: